Detalles de la búsqueda
1.
Clinical observation of peripheral nerve injury in 2 patients with cancer after radiotherapy.
Contemp Oncol (Pozn)
; 17(2): 196-9, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23788990
2.
Corrigendum: Nitazoxanide, an antiprotozoal drug, reduces bone loss in ovariectomized mice by inhibition of RANKL-induced osteoclastogenesis.
Front Pharmacol
; 14: 1247393, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37564185
3.
Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis.
Front Pharmacol
; 12: 781640, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34955850
4.
[Clinical study of aromatase inhibitors in advanced breast cancer].
Beijing Da Xue Xue Bao Yi Xue Ban
; 39(2): 193-6, 2007 Apr 18.
Artículo
en Zh
| MEDLINE | ID: mdl-17440599
5.
[Observation and clinical significance of adjuvant chemotherapy-induced amenorrhea in premenopausal breast cancer patients].
Zhonghua Zhong Liu Za Zhi
; 28(11): 848-51, 2006 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-17416008
6.
[Expression of epidermal growth factor receptor-2 in Chinese breast cancer patients: a meta-analysis].
Beijing Da Xue Xue Bao Yi Xue Ban
; 38(2): 184-8, 2006 Apr 18.
Artículo
en Zh
| MEDLINE | ID: mdl-16617363
7.
Prediction of recurrence risk in early breast cancer using human epidermal growth factor 2 and cyclin A2.
Chin Med J (Engl)
; 123(4): 431-7, 2010 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20193482
Resultados
1 -
7
de 7
1
Próxima >
>>